Provectus Biopharmaceuticals Establishes Research
KNOXVILLE, TN, July 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program...
Source: globenewswire.com
Stay updated with breaking news from Retinal Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KNOXVILLE, TN, July 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program...